Rabbit oral papillomavirus (ROPV) induces warts in mucosal tissues, and represents a useful model for understanding host -virus interactions that are reflected in mucosal/HPV infections. ROPV induces benign papillomas that regress in 100% of infected rabbits. We previously reported the complete genome sequence of ROPV. However, the oncogenic potential of this virus is unknown because of immunologically mediated regression. The purpose of this study was to characterize the transforming proteins of E6, E7, and E8 genes of ROPV. E6, E7, and E8 genes of ROPV were cloned into the expression vector PCR3. Two hybrid CRPV-ROPV E6 genes were also constructed and tested together with the three wild-type ROPV genes. Each construct was transfected into NIH3T3 cells and stable transfected cell lines were established. Transforming properties of ROPV E6, E7, and E8 were tested via anchorage-independent growth of cells in agar plates and tumor growth in athymic mice. Cells with ROPV E6, E7, or E8 formed colonies in agar and tumors in athymic mice. These observations suggest that ROPV E6, E7, and E8 are oncogenic.
Introduction
Rabbit oral papillomavirus (ROPV) causes benign lesions on the tongue and the oral cavity of domestic rabbits (Parsons and Kidd, 1936; Parsons and Kidd, 1942) . Unlike the cottontail rabbit papillomavirus (CRPV), which can induce persistent papillomas and malignant tumors in cutaneous tissues, ROPV-induced lesions usually regress at about 60 days after infection. Both rabbit viruses show tissue and species restriction in infectivity. In early studies, morphological features of ROPV-induced lesions were examined by electron microscopy (Rdzok et al., 1966; Richter et al., 1964; Sundberg et al., 1985) . We previously demonstrated that infectious stocks of ROPV could be produced from mouse xenografts of ROPV-infected rabbit tissue (Christensen et al., 1996) . In addition, a ROPV/rabbit genital infection model was established in our laboratory (Harvey et al., 1998) . More recently, the genomic sequence was published and serologic responses to ROPV major capsid protein L1 were examined (Christensen et al., 2000; O'Banion et al., 1988) . Another study demonstrated that immunization with peptides of the minor capsid protein, L2, of ROPV provided protective immunity against virus infection (Embers et al., 2002) .
Finally, a recent study comparing the life cycle of different papillomaviruses suggested that ROPV was an appropriate virus system to study the life cycle of mucosal HPV types and for the development of prophylactic vaccines (Peh et al., 2002) .
The ROPV genome is about 8 kb in size and shows similar organization of open reading frames (ORFs) with that of CRPV (60% identical) and other PV genomes. There are seven early ORFs (E1, E2, E4, E5, E6, E7, and E8) and two late ORFs (L1 and L2). When amino acid sequences of the ORFs of ROPV, CRPV, COPV, and BPV4 are compared, CRPV shows highest similarity to ROPV in all the viral proteins (Christensen et al., 2000; Han et al., 1998) . CRPV gene function has been well characterized and E6, E7, E8, and E5 have been identified as oncogenes (Han et al., 1998; Harry and Wettstein, 1996; Hu et al., 2002a; Meyers et al., 1992) . Using the CRPV DNA/rabbit infection model, investigators identified that E6 and E7 genes are essential for CRPV infection in vivo because CRPV E6 and E7 ATG knockout genomes failed to induce papillomas. However, E8 and E5 knockouts do not abrogate CRPVinduced papillomas although E8 knockout genome demonstrated reduced papilloma growth rate (Hu et al., 2002a) . In this study, we demonstrated that ROPV E6, E7, and E8 were oncogenic with E8, showing weaker transforming activity to E6 when tested for colony formation in soft agar and for tumor growth in nude mice. To further characterize the function of the ROPV E6 gene, we established two hybrid CRPV-ROPV E6 genes and tested these hybrid proteins for oncogenicity both in vitro and in vivo. Cells with both hybrid E6 gene products formed cell colonies in soft agar and one of them induced tumors in nude mice. Because ROPV DNA/rabbit infection model has not been established yet, we used CRPVDNA/rabbit infection model with the hybrid ROPV E6 genes in the context of CRPV to test oncogenicity and function of these hybrid genes in the context of the whole viral genome.
Results
ROPV E6, E7, E8, R-CE6*, and R-CE6** are transcribed in vivo and translated in vitro ROPV E6, E7, and E8 expression in transfectants was determined by reverse-transcriptase polymerase chain reaction (RT-PCR) to detect mRNA. Primer pairs specific for the different genes were used. RNA extracted from the vectortransfected cells was tested for amplification with all the primer pairs as a control. No band was present from vectortransfected cells while specific E6, E7, and E8 bands were observed (data not shown).
To measure expression efficiencies, a coupled T7 transcription/translation kit and Transcendk non-radioactive translation detection system was used. As expected, positive control (luciferase) showed a strong band at around 60 kDa. Vector alone did not produce any product. ROPV E6, R-CE6*, and R-CE6** expressed products at the expected size (about 30 kDa). However, E8 produced a band that was larger than its theoretically expected MW of 5-6 kDa and no E7 product was detectable ( Fig. 1A) .
Because the reticulocyte lysate assay had been reported to be problematic for the expression of HPV E7 genes, we hypothesized that a similar problem might exist in the expression of rabbit papillomavirus E7. We thus applied the wheat germ extract systems to the expression of these E7 genes. The corresponding bands of the E7 products were detected using this expression system ( Fig. 1B) .
Cell proliferation in cell lines transfected with ROPV genes
All viral gene-transfected cell lines showed increased growth rates when compared to that of the vector-transfected cells when grown in low concentrations of fetal bovine serum (data not shown). When plated into soft agar, these cell lines formed significantly more colonies (diameter > 0.2 mm) than those of the cells containing vector alone (Fig. 2) . The ROPV E6-transfected line showed more vigorous growth compared to cells containing R-CE6* and E8 ( P < 0.05). However, no significant differences were found in colony number between ROPV E7-transfected cell lines and those containing E6, R-CE6**, or E8.
Tumor formation in nude mice
Four athymic nu/nu mice per group were injected with ROPV E6, E7, E8, and R-CE6** stably transfected cells (5 Â 10 6 ), respectively. Tumors appeared in mice injected with ROPV E6 and E7-transfected cells 3 weeks later. The nu/nu mice were sacrificed at week 5 after inoculation of cells, and tumors were measured and harvested for histology and immunoanalyses. The mean size of the tumors in mice injected with cells containing ROPV E6 was significantly Fig. 1 . (A) In vitro translation from various constructs. All viral genes were cloned into the PCR3 expression vector and sequenced before expression. One microgram of each plasmid was used in the TNT Quick coupled transcription/translation system (Promega, WI) and detected by the Transcendk nonradioactive translation detection system. CRPV E6, CRPV E6G252E, R-CE6*, R-CE6**, and ROPV E6 were translated at the expected size. The ROPV E8 product was larger than predicted and no E7 product was observed. (B) Expression of ROPV E7 in wheat germ extract expression systems. Lane 1 is the negative control; lane 2 and 3 are the CRPV E7 products; lane 4 is the ROPV E7 protein.
larger than those tumors in mice injected with E8 or R-CE6** cells. No significant difference was detected between tumor sizes initiated from cell lines transfected with ROPV E7, and E6 or E8. One small tumor was observed at a site injected with vector only cells.
The tumors induced by the cells containing ROPV E6 was locally malignant as compared to tumors established from cells containing ROPV E7, E8, and R-CE6** (Fig. 3 ). ROPV E6 plus E7 genes were visible in these tumors by DNA in situ hybridization (Fig. 4) . The presence of each gene in these tumors was identified by PCR amplification (data not shown).
Growth of hybrid E6 CRPV genomes in rabbit skin
CRPV genomes containing the hybrid CRPV-ROPV E6-E8 genes R-CE6* and R-CE6** (Fig. 5 ) were tested for viability by inoculation onto scarified rabbit back skin. Interestingly, neither construct produced papillomas. Wildtype CRPV genomes produced papillomas under the same experimental inoculation conditions (data not shown).
Discussion
ROPV is a mucostropic papillomavirus that shares similarity in life cycle with human mucosal papillomaviruses (Peh et al., 2002) . Analysis of ROPV gene function, however, lags that of the more extensively studied rabbit cutaneous CRPV. In this study, we described the characterization of three ROPV oncogenes and also included analysis of two hybrid CRPV-ROPV E6 genes. These data provided new information on the oncogenic potential of several ROPV genes.
High-risk human papillomavirus E6 and E7 genes have been widely studied because of their up-regulated expression in cervical carcinomas (Tommasino and Crawford, 1995; Von Knebel, 1992) . These two genes are indispensable for cell transformation in vitro and for papilloma formation in vivo (Harry and Wettstein, 1996; Schmitt et al., 1994; Zhang et al., 1999) . In contrast to wild-type CRPV infection that induces persistent and malignant papillomas in cutaneous tissues in domestic rabbits, ROPVinduced lesions rarely became persistent. All of the lesions regress via immunological mechanisms around 60 days after infection (Christensen et al., 2000) . This regression phenomenon resembles a regressive CRPV strain and many high-and low-risk genital human papillomavirus infections. We had hypothesized that the apparent benign phenotype of ROPV infections suggested that ROPV E6 and E7 might Fig. 2 . Frequency of colonies in agar after P-Iodonitrotetrazolium violet (PI, Sigma) staining. Colonies larger than 0.2 mm in diameter were enumerated using an auto count machine (Dynatech Laboratories, Inc. Imaging products). Significant differences were found between all the transfected cells when compared with that of the control group. Data are representative of three individual experiments. Fig. 3 . Tumor formation in nude mice following inoculation with different transfected cells. Nude mice (5 -6 weeks of age) were injected subcutaneously with 5 Â 10 6 ROPV E6, E7, E8, or vector-transfected cells. Five weeks later, the mice were sacrificed and tumors were measured. The geometric mean diameter (GMD) of individual tumors was calculated. The bars represent the mean GMD F SE of each group of mice (N = 4). Tumors from cells transfected with ROPV E6 induced larger tumors than those of E8-transfected cells. No significant difference was noticed between ROPV E7 versus tumors induced by cell transfected with E6 or E8.
have a lower oncogenic potential when compared with CRPV E6 and E7. However, immunologically mediated regressions prevented such an analysis on intact host tissues. Our results demonstrated that ROPV E6 and E7 showed much higher transforming activities in vitro when compared with their counterpart CRPV oncogenes. The ROPV E6transfected cell line induced tumors in nude mice with invasive morphology. Despite high in vitro oncogenic potential of ROPV E6, E7, and E8, ROPV causes benign and regressive infections in rabbits. Several possibilities may account for the benign nature of ROPV infection in the context of the whole genome. The ROPV upstream regulatory region (URR) was identified as a weaker promoter when compared to that of CRPV (Peng, unpublished observations). Alternatively, ROPV E6 may be highly antigenic in vivo as found for the E6 protein of a regressive strain of CRPV as described previously (Hu et al., 2002b; Salmon et al., 1997) . Thus, ROPV E6 may be a key immunological target leading to ROPV-induced papilloma regression.
ROPV E7 was not detected by in vitro Reticulocyte Lysate Systems although we detected good levels of E7 transcription in transfected cell lines (data not shown). A recent study showed that expression levels of E7 were inhibited by a specific interaction between a peptide, SEQIKA, shared by Rabbit a1-Globin and Human Cytokeratin 7 and the viral transcript T (De Pasquale and Kanduc, 1998; Kanduc, 2002) . Similar regulatory events may occur for both CRPV and ROPV E7 expression in vitro because we also found CRPV E7 to be poorly expressed via in vitro transcription (Han et al., 1999) . However, E7 proteins were detectable by in vitro translation using the Wheat Germ Extract Systems (Fig. 1B) . In addition to peptide inhibition, reduced expression of wild-type HPV-16 E7 has been attributed to sub-optional codon usage (Cid-Arregui and Juarez, 2003; Liu et al., 2002) . We also observed that the rabbit papillomavirus E7 proteins were expressed at high levels in insect cells using recombinant baculoviruses but at much lower or undetectable levels in mammalian cells (Hu et al., unpublished data) .
ROPV E8 is highly homologous in DNA sequence with CRPV E8 but has only 40% identity in amino acid residues. CRPV E8 has been identified as a weak oncogene but is highly antigenic in vaccination studies. E8 also plays a role in the appearance and outgrowth of CRPV-induced papillomas (Hu et al., 2002a) . In this study, we also found that ROPV E8 has weaker transforming activity when compared to ROPV E6.
Most interestingly, two hybrid CRPV-ROPV E6 genes also showed high transforming activity in soft agar and one of these hybrid E6 genes induced tumors in nude mice. Using the same in vitro assays, we were not able to see vigorous colony formation of the wild-type CRPV E6transfected cells although these cells showed proliferative capacity in medium containing low fetal bovine serum. The R-CE6** (CRPV E6 with the carboxyl terminal of ROPV E6)-transfected cells formed significantly more colonies than did cells transfected with CRPV E6 in the anchorageindependent assay. In a previously published paper, some CRPV E6 mutants were found to be more active in cell transformation than was wild-type CRPV E6. These investigators hypothesized that mutations in E6 might lead to improved binding of E6 to P53, E6AP, E6BP, etc. and thus be more oncogenic (Harry and Wettstein, 1996; Meyers et al., 1992) . We did not determine whether ROPV E6 and the hybrid CRPV-ROPV E6 proteins shared increased associations with P53, E6AP, or E6BP. Although R-CE6** genetransfected cells formed comparable numbers of colonies as did ROPV E6 in soft agar, tumors in athymic mice were smaller. A similar phenomenon was reported in previous studies (Harry and Wettstein, 1996) .
Our data imply that the carboxyl-terminal portion of ROPV E6 (including E8) might be important for the oncogenicity of this gene. Unfortunately, functional studies Fig. 5 . Generation of hybrid CRPV-ROPV E6 genes. Two enzyme sites (MscI and HpaI) at the borders of ROPV and CRPV E8 genes were introduced by sitedirect mutagenesis in ROPV E6 and CRPV E6, respectively. CRPV E8 or the carboxyl region of CRPV E6 (including E8) were replaced by ROPV and named R-CE6* and R-CE6**. The highlighted residues are identical between CRPV and ROPV E6 and E8 genes. on these hybrid CRPV-ROPV E6 genes in the context of ROPV DNA infection in rabbits are not currently possible. We have been unable to generate ROPV infections using purified and/or plasmid-derived ROPV DNA. We did test two CRPV constructs containing these two CRPV-ROPV hybrid E6 genes, respectively, and found that they were not able to induce cutaneous papillomas in rabbits.
Materials and methods

Constructs
Primers for amplification of ROPV E6 (upstream primer: 5V-AAT-TAG-ATC-TAT-GGA-GGA-GCG-CCA-CGC-ACC-TTG-G-3V; downstream primer: 5V-CGG-GGG-ATC-CTG-AGC-AAG-AAG-CTT-AAA-CGT-TAA-T-3V), E7 (upstream primer: 5V-ATG-CAA-GCT-TAT-GAT-AGG-CCC-CAA-GCC-TAC-CCT-T-3V; downstream primer: 5V-GCC-AGA-TAT-CTT-CAG-CCA-TTT-TTC-AGA-CGT-TTG-C-3V), and E8 (upstream primer: 5V-GGA-TCC-ACG-GGT-GGC-CTC-ATG-G-3V; downstream primer: 5V-GGT-ACC-AGA-CGT-AGT-TAG-CAC-TC-3V) were synthesized in the core facility at the Hershey Medical Center and designed from the published ROPV sequence (Christensen et al., 2000) . For construction of the two hybrid CRPV-ROPV E6 genes, two restriction enzyme sites were introduced by site-directed mutagenesis at the borders of both CRPV E8 and ROPV E8 in CRPV and ROPV E6 subclones. Hybrid CRPV-ROPV E8 (R-CE6*) represented the E8 of CRPV replaced by ROPV E8, and hybrid CRPV-ROPV E6 (R-CE6**) represented the carboxyl-terminal region of CRPV E6 (including CRPV E8) replaced by the equivalent part of ROPV (Fig. 5) . The rationale for construction of these two hybrid E6 genes was to test the role of ROPV E8 (e.g. construct R-CE6*) in vivo in the context of potential infectability within CRPV genome. The second construct replaced CRPV E6 (with ROPV E8) and generated a CRPV-ROPV E6 hybrid gene that replaced the highly antigenic carboxyl-terminal portion of CRPV E6 with ROPV E6 to test altered host immune responses (Hu et al., 2002b) . All genes were cloned into an expression vector (PCR3), which contained a neomycin (G-418) resistance gene under the control of the CMV promoter (Invitrogen) and constructs were verified by automated sequencing.
Cell culture and transfections
NIH3T3 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and penicillin (100 units/ml) and streptomycin (100 Ag/ml). Detachment and dispersion of cells was achieved by a brief exposure to 0.25% trypsin, 0.02% EDTA in PBS.
All transfections were performed by calcium phosphate precipitation (Han et al., 1998) . Cells used for DNA transfection were plated at 70% confluence in T-25 flasks. Ten micrograms of circular plasmid DNA was used in transfections. G-418 (Geneticin, Gibco BRL)resistant selection began 24 h after DMSO shock by the addition of 1 mg/ml G-418. G418-resistant colonies were pooled after a 2-week period of selection and maintained with medium containing 1 mg/ml G418. All cell cultures were maintained at 37 jC in a 5% CO 2 humidified atmosphere.
Detection of gene transcription by RT-PCR
The transcripts of ROPV E6, E7, E8, R-CE6*, R-CE6**, and vector-transfected NIH3T3 cells were detected by standard RT-PCR analysis. In brief, total RNA from each stable transfected cell line (1 Â 10 6 cells) was extracted with Trizol reagent (Gibco BRL) and amplified using an RT-PCR reaction kit (Roche) with corresponding primers.
In vitro translation
One microgram of each expression construct was translated with non-radioactive TNT Quick T7 coupled Transcription/Translation kit (Promega) according to the protocol provided by the manufacturer. One microliter of final reaction product was mixed with 10 Al protein loading buffer and denatured at 100 jC for 5 min. The samples were separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (12%) and transferred to polyvinylidene difluoride (PVDF) membranes. After blocking and incubation with avidin-AP, the proteins were detected with the Transcendk non-radioactive translation detection system (Promega).
CRPV E7 and ROPV E7 products were expressed in TNTR Coupled Wheat Germ Extract Systems (Promega) according to the protocol provided by the manufacturer.
[ 35 S]methionine was incorporated into the expressed proteins. Five microliters of final reaction product was mixed with 20 Al protein loading buffer and denatured at 100 jC for 5 min. The samples were separated using SDS-polyacrylamide gel electrophoresis (12%). The gel was placed on a sheet of WhatmanR 3MM filter paper, and dried at 80 jC for 30 -90 min under a vacuum using a conventional gel dryer. The dried gel was exposed on X-ray film for 1 -6 h at À70 jC.
Cell growth and anchorage-independent assay 5 Â 10 3 cells from vector, ROPV E6, E7, E8, R-CE6*, and R-CE6**-transfected cells were plated into 96-well plates with culture medium containing 2% fetal bovine serum. The cells were stained with MTT (7.5 mg/ml medium) for 3 h at 37 jC then lysed with lysis buffer (10% Triton X-100, 0.01 N HCl in isopropyl alcohol). The absorbance of the solubilized purple dye released by live cells was determined at 570 nm using an automated microplate reader (Opsys MRk, Thermolabsystems). The mean OD value of duplicate cultures for each cell was calculated. Growth curves were plotted as mean OD values against time after the cells were seeded. For detection of anchorage-independent growth, 2 Â 10 5 pooled and expanded G-418-resistant cells from selected cell lines were plated in 60-mm petri dishes with medium containing 0.3% agar Noble (DiFco Laboratories). The dishes contained a bottom layer of 0.5% Nobel agar in medium containing G-418. Cells were fed twice weekly with 1 ml of 0.3% Noble agar medium. Five weeks after seeding, colonies were stained with P-Iodonitrotetrazolium Violet (2-[4-Iodophenyl]-3-[-4nitrophenyl]-5-phenyltetrazolium chloride, Sigma) overnight at 37 jC in the dark. Colonies greater than 0.2 mm in diameter were enumerated using an auto count machine (Dynatech Laboratories, Inc.).
Tumorigenesis assay
5 Â 10 6 pooled and expanded G-418-resistant cells from ROPV E6, E7, E8, and R-CE6**-transfected cell lines, respectively, were injected subcutaneously into individual nude mice. Tumor formation was checked weekly after the cell inoculation. Five weeks later, the nude mice were sacrificed and the tumors were measured and tumor tissues fixed in formalin for histological examination.
Growth of CRPV genomes with hybrid E6 genes in vivo
Hybrid CRPV-ROPV E6 genes (Fig. 5) were replaced into the entire CRPV genome using procedures previously described (Hu et al., 2002b) . The modified genomes were tested for infectivity on NZW rabbit cutaneous sites following inoculation of 10 Ag DNA per site onto scarified hyperplastic skin as previously described (Hu et al., 2002b) .
Statistical analyses
The mean size of the tumors was determined by geometric mean diameter (GMD). Differences in mean tumor size between the groups were determined by Student's T test at P < 0.05 level of significance.
